Clinical Trials in Xiangyang, China
Locations / Xiangyang, China
Delta Trials lists 134 clinical trials conducted in Xiangyang, China, making it a notable site of clinical research activity. These trials addressing 190 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Xiangyang research landscape.
134
Total Trials
190
Conditions
3
Terminated since 2020
Browse by condition (190 total)
- Non-small cell lung cancer 13 trialsAll Non-small cell lung cancer trials
- Acute ischemic stroke 7 trialsAll Acute ischemic stroke trials
- Breast cancer 6 trialsAll Breast cancer trials
- Breast neoplasms 3 trialsAll Breast neoplasms trials
- Marginal zone lymphoma 2 trialsAll Marginal zone lymphoma trials
- Triple negative breast cancer (tnbc) 2 trialsAll Triple negative breast cancer (tnbc) trials
- Advanced solid tumour 2 trialsAll Advanced solid tumour trials
- Small cell lung cancer 2 trialsAll Small cell lung cancer trials
- Diabetes mellitus, type 2 2 trialsAll Diabetes mellitus, type 2 trials
- Cardiovascular diseases 2 trialsAll Cardiovascular diseases trials
- COVID-19 2 trialsAll COVID-19 trials
- All Esophageal squamous cell carcinoma (escc) trials
- Rabies 2 trialsAll Rabies trials
- Heart failure 2 trialsAll Heart failure trials
- Hyperaldosteronism 2 trialsAll Hyperaldosteronism trials
- Non-small cell lung cancer (nsclc) 2 trialsAll Non-small cell lung cancer (nsclc) trials
- Epithelial ovarian cancer 2 trialsAll Epithelial ovarian cancer trials
- Hypertension 2 trialsAll Hypertension trials
- Urothelial carcinoma 2 trialsAll Urothelial carcinoma trials
- Thrombosis 1 trialAll Thrombosis trials